The Clinical and Diagnostic Significance of Anti-myosin Autoantibodies in Cardiac Disease (Q37826114)

23 August 2017

1 reference

title

The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac disease (English)

1 reference

23 August 2017

The Clinical and Diagnostic Significance of Anti-myosin Autoantibodies in Cardiac Disease (English)

1 reference

DOI

https://api.crossref.org/works/10.1007/S12016-010-8229-8

21 November 2024

0 references

1 reference

2

Yehuda Shoenfeld

1 reference

23 August 2017

1

Udi Nussinovitch

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21207194

21 November 2024

publication date

1 February 2013

1 reference

23 August 2017

February 2013

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21207194

full work available at URL

21 November 2024

http://link.springer.com/content/pdf/10.1007/s12016-010-8229-8.pdf

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

http://link.springer.com/article/10.1007/s12016-010-8229-8/fulltext.html

21 November 2024

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

http://link.springer.com/content/pdf/10.1007/s12016-010-8229-8

21 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Clinical Reviews in Allergy & Immunology

21 November 2024

published in

1 reference

23 August 2017

volume

44

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

98-108

1 reference

Autoimmunity and heart diseases: pathogenesis and diagnostic criteria

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Autoantibody-mediated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Anti-troponin autoantibodies and the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

HLA-DQB1* polymorphism and associations with dilated cardiomyopathy, inflammatory dilated cardiomyopathy and myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Association of HLA class II DRB1, DPA1 and DPB1 polymorphism with genetic susceptibility to idiopathic dilated cardiomyopathy in Chinese Han nationality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

MHC class II alleles in Mexican patients with rheumatic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Transforming growth factor-beta inhibits coxsackievirus-mediated autoimmune myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Characterization of anti-heart antibodies in mice after infection with coxsackie B3 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Infection, vaccines and other environmental triggers of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Recurrent pericarditis: infectious or autoimmune?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Stress as a trigger of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Functional autoantibodies, a new paradigm in autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Pathological autoantibodies in cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Detection of antibodies in cardiac autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Induction of myocarditis and valvulitis in lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Autoimmunity to alpha myosin in a subset of patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Immunoglobulin isotype determines pathogenicity in antibody-mediated myocarditis in naïve mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Identification of a putative shared epitope between Coxsackie virus B4 and alpha cardiac myosin heavy chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Review of microbial infections and the immune response to cardiac antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Lack of T cell response to cardiac myosin and a reduced response to PPD in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

A cardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Cardiac myosin autoimmunity in acute Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Myosin: a link between streptococci and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Cardioprotective effects of carvedilol on acute autoimmune myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Prevention of myosin-induced autoimmune myocarditis in mice by anti-L3T4 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

L.E.A.P.S. heteroconjugate is able to prevent and treat experimental autoimmune myocarditis by altering trafficking of autoaggressive cells to the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Myocarditis: infection versus autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Interferon beta-1b therapy in chronic viral dilated cardiomyopathy--is there a role for specific therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Lack of natural antibodies in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8229-8

Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease

21 January 2018

2 references

https://api.crossref.org/works/10.1007/S12016-010-8229-8

21 January 2018

12 December 2020

Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Organ-specific cardiac autoantibodies in dilated cardiomyopathy--an update

1 reference

12 December 2020

Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications

1 reference

12 December 2020

Coxsackievirus induced myocarditis in mice: cardiac myosin autoantibodies do not cross-react with the virus.

1 reference

12 December 2020

Heart-specific autoantibodies induced by Coxsackievirus B3: identification of heart autoantigens

1 reference

12 December 2020

The mosaic of autoimmunity

1 reference

12 December 2020

Myosin autoimmunity is not essential for cardiac inflammation in acute Chagas' disease

1 reference

12 December 2020

Cellular autoimmunity to cardiac myosin in patients with a recent myocardial infarction

1 reference

12 December 2020

Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis

1 reference

12 December 2020

Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis

1 reference

12 December 2020

The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008.

1 reference

12 December 2020

Nasal administration of cardiac myosin suppresses autoimmune myocarditis in mice

1 reference

12 December 2020

Cardiac myosin induces myocarditis in genetically predisposed mice.

1 reference

12 December 2020

Antimyosin antibodies in CNS-lupus

1 reference

12 December 2020

Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis.

1 reference

12 December 2020

Vaccination infection and autoimmunity: myth and reality VIAMR 2005-10-26-28, Beau-Rivage Palace Hotel, Lausanne, Switzerland

1 reference

12 December 2020

The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases--2008.

1 reference

12 December 2020

Myosin-induced acute myocarditis is a T cell-mediated disease

1 reference

12 December 2020

The prevalence of autoantibodies to: myosin, troponin, tropomyosin and myoglobin in patients with circulating triiodothyronine and thyroxine autoantibodies (THAA)

1 reference

12 December 2020

Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein.

1 reference

12 December 2020

Cardiac autoimmunity in HIV related heart muscle disease

1 reference

12 December 2020

Human cardiac myosin autoantibodies impair myocyte contractility: a cause-and-effect relationship

1 reference

12 December 2020

Induction of antigen specific peripheral humoral tolerance to cardiac myosin does not prevent CB3-mediated autoimmune myocarditis

1 reference

12 December 2020

Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis

1 reference

12 December 2020

Pre- and post-transplant anti-myosin and anti-heat shock protein antibodies and cardiac transplant outcome

1 reference

12 December 2020

Immune tolerance to cardiac myosin induced by anti-CD4 monoclonal antibody in autoimmune myocarditis rats

1 reference

12 December 2020

Autoimmune mechanisms in cardiovascular diseases

1 reference

12 December 2020

Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients

1 reference

12 December 2020

Relationship between HLA-DQA1 polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy.

1 reference

12 December 2020

Anti-myosin autoantibodies are more frequent in non-Chagasic cardiomyopathy than in Chagasic cardiomyopathy patients

1 reference

12 December 2020

Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. The Myocarditis Treatment Trial Investigators

1 reference

12 December 2020

Epitopes Shared between Coxsackievirus B3 (CVB3) and Normal Heart Tissue Contribute to CVB3-Induced Murine Myocarditis

1 reference

12 December 2020

Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis

1 reference

12 December 2020

Anti-human cardiac myosin autoantibodies in Kawasaki syndrome

1 reference

12 December 2020

Antigens of the major histocompatibility system in ischemic heart disease and idiopathic dilated cardiomyopathy

1 reference

12 December 2020

The mosaic of autoimmunity: genetic factors involved in autoimmune diseases--2008.

1 reference

12 December 2020

IgG subclass reactivity to human cardiac myosin in cardiomyopathy patients is indicative of a Th1-like autoimmune disease

1 reference

12 December 2020

Mimicry and antibody-mediated cell signaling in autoimmune myocarditis

1 reference

12 December 2020

Effect of anti-cardiac myosin antibody on prognosis of patients with acute myocardial infarction

1 reference

12 December 2020

Identifiers

DOI

1 reference

23 August 2017

1 reference